Preimplantation Genetic Diagnosis Market, By Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single gene disorders, HLA Typing, Gender Selection, Others), By End User (Diagnostic Laboratories, Hospitals, Clinics, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jul 2024

Code : CMI698

Pages :188

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Key Developments

In May 2024, Takara Bio USA, Inc., a subsidiary of Takara Bio Inc., has launched the Lenti-X Transduction Sponge, a novel microfluidic transduction enhancer for lentivirus-mediated gene delivery. This innovative product simplifies the process with a walkaway workflow, achieving high transduction efficiency across cell types. President & CEO Carol Lou highlighted its potential to revolutionize viral transduction methods, offering a reliable and non-toxic alternative to chemical enhancers, thereby streamlining research and reducing costs.
In April 2024, GenEmbryomics Limited, a trailblazer in advanced genetic testing services for embryos, and Progenesis Inc, a top provider of preimplantation genetic testing for in vitro fertilization (IVF), have announced a transformative partnership aimed at expanding access to state-of-the-art reproductive technologies.
In June 2023, Kindbody, a prominent fertility clinic network and provider of family-building benefits for employers, has launched Kindlabs, its new genetic testing division. This addition integrates genomics into Kindbody's comprehensive care model, enhancing patient services. Kindlabs operates a state-of-the-art reference laboratory spanning 8,000 square feet in Secaucus, NJ.